← FDA Drug Approvals (Drugs@FDA)
HALOBETASOL PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ENCUBE · Approved 2018-03-20
Drug application
- FDA Application #
ANDA209978- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HALOBETASOL PROPIONATE
- Generic name
- Halobetasol Propionate
- Active ingredients
- HALOBETASOL PROPIONATE
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- ENCUBE
- First approval
- 2018-03-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown